RaQualia’s CEO Featured in "Pharmaceutical Executive Magazine":
Selected as One of 30 Leaders Globally Who Have Made a Difference

RaQualia Pharma Inc. (RaQualia) [JASDAQ Growth: 4579] announced today that President & CEO Atsushi Nagahisa was chosen by Pharmaceutical Executive Magazine as one of 30 leaders who have shaped the global pharmaceutical industry over the past 30 years.  The list includes individuals from various disciplines within the life sciences, including scientists, administrators, industry leaders, and public policy makers.  The cover feature appears in the October 2011 issue, commemorating the magazine’s 30th anniversary as a premier publication in the biopharmaceutical sector.

In response to this selection, Dr. Nagahisa said, “It is a tremendous honor to be included in a list with so many people whom I have admired for many years.  I am very grateful to have the opportunity to pursue innovation in the life sciences.  Every single day brings opportunities to try to help patients who are waiting for new and better therapies.”

The complete list of 30 is below for your reference:

Dr. Francis Collins, Director, National Institutes of Health
Dr. P. Roy Vagelos, Chairman Emeritus, Merck
Fernand Sauer, First Director General, European Medicines Agency
Sir Michael Rawlins, Chairman, UK National Institute for Health and Clinical Excellence
Dr. Mark McClellan, Director, Engelberg Center for Health Reform, Brookings Institution
Henry Waxman (D-California), Member, U.S. House of Representatives
Dr. Janet Woodcock, Director, FDA Center for Drug Evaluation and Research
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
Dr. Harvey Bale, Jr., former Director General, IFPMA
Dr. Carlos Morel, Director for Technical Development in Health, Oswaldo Cruz Foundation
Dr. Henry Grabowski, Professor of Economics, Duke University
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
Andrew Witty, Chairman & CEO, GlaxoSmithKline
Dr. Atsushi Nagahisa, President & CEO, RaQualia Pharma Inc.
Fred Frank, Vice Chairman, P.J. Solomon Co.
Dennis Gillings, Chairman & CEO, Quintiles Transnational Corp.
Dr. Peter Piot, Director, London School of Hygiene and Tropical Medicine
Angus Russell, CEO, Shire
Dr. Jane Henney, Former FDA Commissioner
Dr. Antonio Gotto, Dean, Weill Cornell Medical College
Sir Martin Sorrell, CEO, WPP
Y.K. Hamied, Chairman, Cipla
Dr. Sidney Wolfe, Director, Public Citizen’s Health Research Group
Josef von Rickenbach, President & CEO, Parexel
Dr. Napoleone Ferrara, Research Fellow, Genentech
Martin Wygod, Chairman, WebMD
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Abbey Meyers, Founder, National Organization of Rare Disorders
Candan Karabagli, CEO, Abdi Ibrahim A.S.
Dr. Daniel Vasella, Chairman, Novartis 

The article on Dr. Nagahisa appears on page 68 of the magazine and can be downloaded as a pdf here.

Pharmaceutical Executive Magazine can be found at the following link: http://pharmexec.findpharma.com/

About RaQualia:
RaQualia Pharma Inc. engages in the discovery, development and marketing of clinical and pre-clinical drug candidates for highly-unmet medical needs including Pain, Inflammation, Cancer, Auto-immune, Alzheimer’s, and GI Diseases.  RaQualia’s vision is to bring people hope, health and happiness with new medicines. For further information, please visit us at www.raqualia.com.

####